Posted on Leave a comment

IndiGo ranked 6th largest carrier in the world by passenger volume in OAG Frequency & Capacity Statistics for March 2022


National, April 12 2022: India’s leading carrier – IndiGo has been ranked the 6th largest airline by passenger volume in the OAG Frequency & Capacity Statistics for March 2022. According to the report, IndiGo had carried more than 2.02 million passengers in the month, as per data collected till 28 March 2022), which the highest for any carrier in Asia.

OAG also called out IndiGo as the fastest growing airlines in the world, with a frequency increase of 41.3% in the month. The report also ranks IndiGo among the Top 10 airlines in the world by seat capacity for the month of March 2022.

The OAG Frequency & Capacity Statistics data lists the 20 largest global airlines by flights based monthly, in addition to statistics on airport and route capacities. IndiGo is the only Indian airline to feature in this list.

Mr. Ronojoy Dutta, Wholetime Director and Chief Executive Officer, IndiGo said, “It is exciting to see IndiGo among the top airlines in the world. It also is a moment of pride for India, and a strong indicator that the nation is bouncing back strongly from the pandemic. With the easing of restrictions around the world, we look forward to opening more routes and frequencies. This will allow an even greater number of passengers to experience an affordable, on-time, safe and hassle-free travel experience, onboard our lean clean flying machine.”

In addition to the capacity increase in March 2022, IndiGo has recently announced the re-introduction of scheduled operations of more than 150 international flights from various airports in India in April. IndiGo has also added several new routes to its domestic network.

About IndiGo

IndiGo is amongst the fastest growing low-cost carriers in the world. IndiGo has a simple philosophy: offer fares that are affordable, flights that are on time, offering a courteous, hygienic, and hassle-free travel experience. With its fleet of 275+ aircraft, the airline is operating over 1500 daily flights and connecting 73 domestic destinations and 24 international destinations. For more information, please visit You can also connect with us on Facebook, Twitter, and Instagram.

About OAG

OAG is a leading global travel data provider which has been powering the growth and innovation of the air travel ecosystem since 1929. Every day, we support millions of journeys across the globe, enabling a simpler, seamless, and more enjoyable travel experience. With the world’s largest network of schedules and status data, and leading-edge analytics tools, we enable our customers to make smarter decisions, better adapt to change, and create exceptional customer experiences. We partner with some of the biggest global brands, airports, airlines, travel operators, and fast- growing start-ups to design the best services available today, and the finest innovations of tomorrow. Headquartered in the UK, OAG has global operations in the USA, Singapore, Japan, Lithuania, and China.

Posted on Leave a comment

Alembic Quarterly Results: India Formulations business up 23% Net Profit Rs 169 crore

Vadodara, November 10th, 2021
Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 30th September 2021.
Financial Highlights
Net Sales for the quarter at Rs 1292 crores.
Net Profit for the quarter at Rs 169 crores.
Net sales for H-1 FY21 at Rs 2618 crores.
Net profit for H-1 FY21 at Rs 334 crores.

Mr. Shaunak Amin, Managing Director, Alembic Pharmaceuticals Limited said “India Branded Formulation business has posted a strong growth rate for the second consecutive quarter. This is attributed to the consistent efforts to redefine our business strategy and customer relationships, leading to a strong operational performance, along with a market outperforming growth across all our key product segments and therapy areas.”

Operational Highlights
International Business
US Generics at Rs 348 crores in the quarter and at Rs 716 Crores for H-1.
Ex-US International Formulations at Rs 197 Crores in the quarter and at Rs 394 Crores for H-1.
5 ANDA approvals received during the quarter; 150 Cumulative ANDA approvals.
3 ANDA filings during the quarter; Cumulative ANDA filings at 214.
India Formulations Business
India Formulations Business at Rs 509 crores in the quarter and at Rs 989 crores in the H-1.
Acute & specialty segment grew faster than represented pharma market.

API Business
API business at Rs 239 crores in the quarter and at Rs 519 crores for H-1.
3 DMF were filed in the quarter.